Approvals/NMPA/Fluticasone Furoate, Umeclidinium Bromide and Vilanterol Trifenatate Powder for Inhalation

Approved

化学药品

Fluticasone Furoate, Umeclidinium Bromide and Vilanterol Trifenatate Powder for Inhalation

Unknown🇨🇳 National Medical Products Administration

Approval Id: 8eX3PMgX07Z
Approval Number: 国药准字HJ20190055
Generic Name: 氟替美维吸入粉雾剂
Generic Name En: Fluticasone Furoate, Umeclidinium Bromide and Vilanterol Trifenatate Powder for Inhalation
Drug Type: 化学药品
Dosage Form: 吸入粉雾剂
Strength: 每泡含糠酸氟替卡松100µg、乌美溴铵62.5µg（按C₂₉H₃₄NO₂计）与三苯乙酸维兰特罗25µg（按C₂₄H₃₃Cl₂NO₅计），递送剂量为糠酸氟替卡松92µg、乌美溴铵55µg（按C₂₉H₃₄NO₂计）与三苯乙酸维兰特罗22µg（按C₂₄H₃₃Cl₂NO₅计）。
Reg Date: 2024-07-23
Expired Date: 2029-07-22

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jul 23, 2024

Approval ID

8eX3PMgX07Z

Type

化学药品